ArticleTranslational vision science & technology2026
Lifetime Standard for Fluorescence Lifetime Imaging Ophthalmoscopy.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The goal of this effort was to develop a simple, reliable, flexible, and readily transferable fluorescence lifetime standard (as a phantom eye) for use in fluorescence lifetime imaging ophthalmoscopes (FLIOs). Methods: We manufactured by 3D-printing a "fundus piece" designed to fit in a commercially available phantom eye that simulates the optics of the eye. The fundus piece contains a chamber subtending the retina which is filled with a liquid solution of a fluorophore already established in the field as a lifetime standard, which can then be imaged in the FLIO. Results: After several trials of design and 3D-printing resins, a design of the fundus piece in a photopolymerizable resin was found which gave low fluorescence background. Similar results (within 5% of the pre-exponential factor-weighted average lifetime in a two-component fit) were obtained in three different FLIOs with two different excitation lasers and two standard fluorophores, in comparison to published values. Conclusions: We conclude that this approach offers a relatively straightforward and flexible means to standardize FLIO instruments. Translational Relevance: Our approach is relevant to clinical translation of FLIO for three reasons: first, it offers the operator a subject-free means to verify that instrument performance is within specifications; second, it can be used to troubleshoot causes of performance shortfalls; and, third, it makes feasible multicenter trials and intercomparison of data obtained with different instruments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.